Sidley Austin

Adam Welland

Deals
1
Latest
Apr 2026

Firm

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Adam Welland was named on, most recent first
Apr 2026 Exclusive global rights to TAK-063 (balipodect) Takeda Pharmaceutical Co.Axsome TherapeuticsAsset saleLegal adviser to Axsome Therapeutics (acquirer)Completed–Pharma+1Axsome Therapeutics acquisition of Exclusive global rights to TAK-063 (balipodect)

Deals where Adam Welland is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.